Oluwaseun A. Oyesanya

Oluwaseun A. Oyesanya

Auto-generated profile, based on publicly available information

Oluwaseun A. Oyesanya

Olabisi Onabanjo University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2024 in Problems of Virology
Verified
Journal Article
Open access
PDF file
HAHafeez A. Adekola
Hafeez A. Adekola
KWKareem A. Wahab
Kareem A. Wahab
OOOmotayo E. Odunsi
Omotayo E. Odunsi
TATobiloba A. Abesin
Tobiloba A. Abesin
OOOluwaseun A. Oyesanya
Oluwaseun A. Oyesanya
Arboviral infections, transmitted to humans primarily through arthropod vectors, constitute a significant global health threat. Arboviruses, such as Dengue, Zika, Chikungunya, and West Nile viruses, continue to cause widespread outbreaks, necessitating advanced diagnostic tools. Emerging technologies including Lab On A Chip (LOC), Lab On A Disc (LOAD), Microfluidic Paper-Based Analytical Devices (µPADS), Lateral Flow Devices, CRISPR-CAS 12/13, Quartz crystal microbalance (QCM), and Nano-Technology are evaluated for their potential to enhance arboviral diagnosis, offering rapid, accurate, and point-of-care solutions. Furthermore, the identification of robust biomarkers, including Inflammatory Cytokines, Antibodies, Endothelial Activation Products and Indicators of Tissue or Organ Damage, is crucial for improving the understanding of disease pathogenesis, prognosis, and treatment response. A comprehensive analysis of potential diagnostics and biomarkers for arboviral infections sheds light on the evolving strategies to combat these medically significant diseases, ultimately contributing to more effective surveillance, diagnosis and management worldwide.

18 July 2024 in Sri Lankan Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
HAH. A. Adekola
H. A. Adekola
DFDeema Fallatah
Deema Fallatah
OOO. A. Oyesanya
O. A. Oyesanya
AAA. T. Amusan
A. T. Amusan
IOI. B. Onajobi
I. B. Onajobi
HEH. O. Egberongbe
H. O. Egberongbe
This study investigated serological evidence for Zika, hepatitis B and rubella virus infection in 92 pregnant women attending a south-west based Nigerian tertiary care centre from January to May 2023. Of the 92 samples, 31 (33.7%), 14 (15.2%), and 90 (97.8%) exhibited seropositivity for Zika, hepatitis B, and rubella virus respectively. Cases of co-positives were also reported, with 28.3% seropositive for both Zika and rubella virus, 10.9% for hepatitis B and rubella virus, and 4.3% for all three viruses. The findings of this study underscore that a considerable portion of participants are susceptible to Zika and hepatitis B virus. Conversely, the majority of the participants appeared to be protected against rubella virus. This study strongly advocates initiation of public awareness campaigns and formulation of vaccination policies targeting women of reproductive age. Such measures are crucial for countering viral infections which could harm the developing foetus and give rise to pregnancy-related complications.